Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Katherine Perez, PhD
Pfizer, Inc.
Disclosure(s): Pfizer: Stocks/Bonds (Public Company)
Poster(s):
(P-642) Attributes of Point-of-Care Nucleic Acid Amplification Tests for Respiratory Syncytial Virus (RSV): Results of a Systematic Literature Review
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET
(P-1151) The in vitro activity of ceftazidime-avibactam against Enterobacterales isolates collected in Latin America as a part of the ATLAS Global Surveillance Program 2019-2023, by β-lactamase carriage
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1314) Activity of aztreonam-avibactam against Enterobacterales isolated from patients with intra-abdominal infection from Europe, Asia, and Latin America (2020-2024).
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1317) Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents Tested against Enterobacterales from European Hospitals Analysed by Infection Type (2022-2024)
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1335) The in vitro activities of aztreonam-avibactam and cefiderocol against metallo-β-lactamase-producing Enterobacterales isolates collected as a part of the ATLAS Global Surveillance Program, 2021-2022
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1336) The in vitro activity of aztreonam-avibactam against KPC-positive and/or ceftazidime-avibactam-resistant Enterobacterales, ATLAS 2019-2023
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1337) Trends in the co-carriage of multiple carbapenemases among clinical Enterobacterales isolates and the in vitro activity of aztreonam-avibactam, ATLAS 2019-2023
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1338) In vitro activity of ceftazidime-avibactam and comparator agents against Pseudomonas aeruginosa stratified by infection source and ward: ATLAS Global Surveillance Program, 2019-2023
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1339) In vitro activity of ceftazidime-avibactam and comparators against Pseudomonas aeruginosa collected worldwide stratified by age group, ATLAS Global Surveillance Program, 2019-2023
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET